Changes in Subject Characteristics in the Denosumab Pivotal Fracture Trial and Its Extension for up to 8 Years. Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Adachi, Jonathan Derrick
  • Lin, CJF
  • Ho, PR
  • Bolognese, MA
  • Bone, HG
  • Hadji, P
  • Papapoulos, S
  • Recknor, C
  • Daizadeh, NS
  • Dakin, P
  • Wagman, RB
  • Ferrari, S

publication date

  • October 2014